{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T05:12:22Z","timestamp":1787807542023,"version":"build-2784847793"},"reference-count":41,"publisher":"The Endocrine Society","issue":"10","license":[{"start":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T00:00:00Z","timestamp":1623456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP18K08500"],"award-info":[{"award-number":["JP18K08500"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","award":["2019087"],"award-info":[{"award-number":["2019087"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000862","name":"Doris Duke Charitable Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000862","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,27]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Context<\/jats:title><jats:p>Adrenocorticotropic hormone (ACTH) can contribute to aldosterone excess in primary aldosteronism (PA) via increased melanocortin type 2 receptor expression. Dynamic manipulation of the hypothalamic-pituitary-adrenal (HPA) axis could assist PA subtyping, but a direct comparison of dynamic tests is lacking.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To investigate plasma steroid differences between aldosterone-producing adenoma (APA) and bilateral PA (BPA) relative to ACTH variations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted comprehensive dynamic testing in 80 patients: 40 with APA and 40 with BPA. Peripheral plasma was collected from each patient at 6 time points: morning; midnight; after 1 mg dexamethasone suppression; and 15, 30, and 60 minutes after ACTH stimulation. We quantified 17 steroids by mass spectrometry in response to ACTH variations in all patients and compared their discriminative power between the 2 PA subtypes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Patients with APA had higher morning and midnight concentrations of 18-hydroxycortisol, 18-oxocortisol, aldosterone, and 18-hydroxycorticosterone than those with BPA (P\u2005&amp;lt;\u20050.001 for all). In response to cosyntropin stimulation, the APA group had larger increments of aldosterone, 18-oxocortisol, 11-deoxycorticosterone, corticosterone, and 11-deoxycortisol (P\u2005&amp;lt;\u20050.05 for all). Following dexamethasone suppression, the APA group had larger decrements of aldosterone, 18-hydroxycortisol, and 18-oxocortisol (P\u2005&amp;lt;\u20050.05 for all), but their concentrations remained higher than in the BPA group (P\u2005&amp;lt;\u20050.01 for all). The highest discriminatory performance between the PA subtypes was achieved using steroids measured 15 minutes post-ACTH stimulation (area under receiver operating characteristic curve 0.957).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Steroid differences between APA and BPA are enhanced by dynamic HPA testing; such noninvasive tests could circumvent the need for adrenal vein sampling in a subset of patients with PA.<\/jats:p><\/jats:sec>","DOI":"10.1210\/clinem\/dgab420","type":"journal-article","created":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T13:08:27Z","timestamp":1623503307000},"page":"e3969-e3978","source":"Crossref","is-referenced-by-count":24,"title":["ACTH Stimulation Maximizes the Accuracy of Peripheral Steroid Profiling in Primary Aldosteronism Subtyping"],"prefix":"10.1210","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1546-6949","authenticated-orcid":false,"given":"Yuta","family":"Tezuka","sequence":"first","affiliation":[{"name":"Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, MI 48109, USA"},{"name":"Division of Clinical Hypertension, Endocrinology and Metabolism, Tohoku University Graduate School of Medicine, Sendai, Miyagi 980-8576, Japan"},{"name":"Division of Nephrology, Endocrinology and Vascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Miyagi 980-8576, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kae","family":"Ishii","sequence":"additional","affiliation":[{"name":"Division of Clinical Hypertension, Endocrinology and Metabolism, Tohoku University Graduate School of Medicine, Sendai, Miyagi 980-8576, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Zhao","sequence":"additional","affiliation":[{"name":"School of Public Health, University of Michigan, Ann Arbor, MI 48109, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuto","family":"Yamazaki","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tohoku University Graduate School of Medicine, Sendai, Miyagi 980-8576, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Morimoto","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Endocrinology and Vascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Miyagi 980-8576, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6600-8641","authenticated-orcid":false,"given":"Hironobu","family":"Sasano","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tohoku University Graduate School of Medicine, Sendai, Miyagi 980-8576, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron M","family":"Udager","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Michigan, Ann Arbor, MI 48109, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumitoshi","family":"Satoh","sequence":"additional","affiliation":[{"name":"Division of Clinical Hypertension, Endocrinology and Metabolism, Tohoku University Graduate School of Medicine, Sendai, Miyagi 980-8576, Japan"},{"name":"Division of Nephrology, Endocrinology and Vascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Miyagi 980-8576, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9831-6190","authenticated-orcid":false,"given":"Adina F","family":"Turcu","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, MI 48109, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2021,6,12]]},"reference":[{"issue":"8","key":"2021110612085587700_CIT0001","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1161\/CIRCULATIONAHA.118.033597","article-title":"Primary aldosteronism: practical approach to diagnosis and management","volume":"138","author":"Byrd","year":"2018","journal-title":"Circulation."},{"issue":"6","key":"2021110612085587700_CIT0002","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1210\/er.2018-00139","article-title":"The expanding spectrum of primary aldosteronism: implications for diagnosis, pathogenesis, and treatment","volume":"39","author":"Vaidya","year":"2018","journal-title":"Endocr Rev."},{"issue":"4","key":"2021110612085587700_CIT0003","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/HYPERTENSIONAHA.118.11086","article-title":"Cellular and genetic causes of idiopathic hyperaldosteronism","volume":"72","author":"Omata","year":"2018","journal-title":"Hypertension."},{"issue":"1","key":"2021110612085587700_CIT0004","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1210\/clinem\/dgaa484","article-title":"International histopathology consensus for unilateral primary aldosteronism","volume":"106","author":"Williams","year":"2021","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2021110612085587700_CIT0005","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1373\/clinchem.2015.251199","article-title":"Mass spectrometry-based adrenal and peripheral venous steroid profiling for subtyping primary aldosteronism","volume":"62","author":"Eisenhofer","year":"2016","journal-title":"Clin Chem."},{"issue":"5","key":"2021110612085587700_CIT0006","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1161\/HYPERTENSIONAHA.114.04453","article-title":"Measurement of peripheral plasma 18-oxocortisol can discriminate unilateral adenoma from bilateral diseases in patients with primary aldosteronism","volume":"65","author":"Satoh","year":"2015","journal-title":"Hypertension."},{"issue":"1","key":"2021110612085587700_CIT0007","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1161\/HYPERTENSIONAHA.119.13866","article-title":"Comprehensive analysis of steroid biomarkers for guiding primary aldosteronism subtyping","volume":"75","author":"Turcu","year":"2020","journal-title":"Hypertension."},{"issue":"9","key":"2021110612085587700_CIT0008","doi-asserted-by":"crossref","first-page":"e2016209","DOI":"10.1001\/jamanetworkopen.2020.16209","article-title":"Use of steroid profiling combined with machine learning for identification and subtype classification in primary aldosteronism","volume":"3","author":"Eisenhofer","year":"2020","journal-title":"JAMA Netw Open."},{"issue":"3","key":"2021110612085587700_CIT0009","doi-asserted-by":"crossref","first-page":"e282","DOI":"10.1210\/clinem\/dgz235","article-title":"Histological characterization of aldosterone-producing adrenocortical adenomas with different somatic mutations","volume":"105","author":"Ono","year":"2020","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2021110612085587700_CIT0010","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1161\/HYPERTENSIONAHA.119.14177","article-title":"Genetic, cellular, and molecular heterogeneity in adrenals with aldosterone-producing adenoma","volume":"75","author":"De Sousa","year":"2020","journal-title":"Hypertension."},{"issue":"1","key":"2021110612085587700_CIT0011","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1161\/HYPERTENSIONAHA.115.06186","article-title":"Genotype-specific steroid profiles associated with aldosterone-producing adenomas","volume":"67","author":"Williams","year":"2016","journal-title":"Hypertension."},{"issue":"2","key":"2021110612085587700_CIT0012","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.mce.2011.07.034","article-title":"Acute and chronic regulation of aldosterone production","volume":"350","author":"Hattangady","year":"2012","journal-title":"Mol Cell Endocrinol."},{"issue":"2","key":"2021110612085587700_CIT0013","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.beem.2018.01.003","article-title":"Aberrant G-protein coupled hormone receptor in adrenal diseases","volume":"32","author":"St-Jean","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"key":"2021110612085587700_CIT0014","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.644382","article-title":"Aldosterone regulating receptors and aldosterone-driver somatic mutations","volume-title":"Front Endocrinol (Lausanne)","author":"Lim","year":"2021;12:644382"},{"issue":"1","key":"2021110612085587700_CIT0015","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1210\/clinem\/dgaa703","article-title":"Aldosterone is aberrantly regulated by various stimuli in a high proportion of patients with primary aldosteronism","volume":"106","author":"St-Jean","year":"2021","journal-title":"J Clin Endocrinol Metab."},{"issue":"20","key":"2021110612085587700_CIT0016","doi-asserted-by":"crossref","first-page":"e3659","DOI":"10.1097\/MD.0000000000003659","article-title":"Gonadotropin-releasing hormone stimulate aldosterone production in a subset of aldosterone-producing adenoma","volume":"95","author":"Kishimoto","year":"2016","journal-title":"Medicine (Baltimore)."},{"issue":"3","key":"2021110612085587700_CIT0017","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1530\/EJE-08-0711","article-title":"Screening for membrane hormone receptor expression in primary aldosteronism","volume":"160","author":"Zwermann","year":"2009","journal-title":"Eur J Endocrinol."},{"issue":"6","key":"2021110612085587700_CIT0018","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/cen.12998","article-title":"Subtype prediction in primary aldosteronism: measurement of circadian variation of adrenocortical hormones and 24-h urinary aldosterone","volume":"84","author":"Kobayashi","year":"2016","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"4","key":"2021110612085587700_CIT0019","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1530\/EC-14-0086","article-title":"Role of endogenous ACTH on circadian aldosterone rhythm in patients with primary aldosteronism","volume":"3","author":"Sonoyama","year":"2014","journal-title":"Endocr Connect."},{"issue":"9","key":"2021110612085587700_CIT0020","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1210\/jc.2011-0573","article-title":"Significance of adrenocorticotropin stimulation test in the diagnosis of an aldosterone-producing adenoma","volume":"96","author":"Sonoyama","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"issue":"9","key":"2021110612085587700_CIT0021","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1507\/endocrj.EJ11-0133","article-title":"Guidelines for the diagnosis and treatment of primary aldosteronism\u2013the Japan Endocrine Society 2009","volume":"58","author":"Nishikawa","year":"2011","journal-title":"Endocr J."},{"issue":"11","key":"2021110612085587700_CIT0022","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1291\/hypres.30.1083","article-title":"Localization of aldosterone-producing adrenocortical adenomas: significance of adrenal venous sampling","volume":"30","author":"Satoh","year":"2007","journal-title":"Hypertens Res."},{"issue":"4","key":"2021110612085587700_CIT0023","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1530\/EJE-14-1161","article-title":"Is there a role for segmental adrenal venous sampling and adrenal sparing surgery in patients with primary aldosteronism?","volume":"173","author":"Satoh","year":"2015","journal-title":"Eur J Endocrinol."},{"issue":"1","key":"2021110612085587700_CIT0024","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0889-8529(05)70115-8","article-title":"Subclinical Cushing\u2019s syndrome","volume":"29","author":"Reincke","year":"2000","journal-title":"Endocrinol Metab Clin North Am."},{"issue":"6","key":"2021110612085587700_CIT0025","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1161\/HYPERTENSIONAHA.118.12064","article-title":"18-oxocortisol synthesis in aldosterone-producing adrenocortical adenoma and significance of KCNJ5 mutation status","volume":"73","author":"Tezuka","year":"2019","journal-title":"Hypertension."},{"issue":"8","key":"2021110612085587700_CIT0026","doi-asserted-by":"crossref","first-page":"e2921","DOI":"10.1210\/clinem\/dgaa343","article-title":"Sex differences in 11-oxygenated androgen patterns across adulthood","volume":"105","author":"Davio","year":"2020","journal-title":"J Clin Endocrinol Metab."},{"key":"2021110612085587700_CIT0027","article-title":"Supplemental data for: ACTH stimulation maximizes the accuracy of peripheral steroid profiling in primary aldosteronism subtyping","author":"Tezuka","year":"2021","journal-title":"zenodo.org"},{"issue":"11","key":"2021110612085587700_CIT0028","doi-asserted-by":"crossref","first-page":"e4066","DOI":"10.1210\/clinem\/dgaa595","article-title":"Prevalence of somatic mutations in aldosterone-producing adenomas in Japanese patients","volume":"105","author":"Nanba","year":"2020","journal-title":"J Clin Endocrinol Metab."},{"issue":"10","key":"2021110612085587700_CIT0029","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1210\/jc.2018-01004","article-title":"Targeted molecular characterization of aldosterone-producing adenomas in white Americans","volume":"103","author":"Nanba","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2021110612085587700_CIT0030","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00000478-198403000-00001","article-title":"Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors","volume":"8","author":"Weiss","year":"1984","journal-title":"Am J Surg Pathol."},{"issue":"3","key":"2021110612085587700_CIT0031","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1161\/HYPERTENSIONAHA.118.10907","article-title":"Tumor cell subtypes based on the intracellular hormonal activity in KCNJ5-mutated aldosterone-producing adenoma","volume":"72","author":"Yamazaki","year":"2018","journal-title":"Hypertension."},{"issue":"2","key":"2021110612085587700_CIT0032","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1530\/EJE-15-0148","article-title":"Integration of transcriptome and methylome analysis of aldosterone-producing adenomas","volume":"173","author":"Murakami","year":"2015","journal-title":"Eur J Endocrinol."},{"issue":"33","key":"2021110612085587700_CIT0033","doi-asserted-by":"crossref","first-page":"E4591","DOI":"10.1073\/pnas.1505529112","article-title":"Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands","volume":"112","author":"Nishimoto","year":"2015","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"12","key":"2021110612085587700_CIT0034","doi-asserted-by":"crossref","first-page":"5867","DOI":"10.1210\/jc.2019-01182","article-title":"Three discrete patterns of primary aldosteronism lateralization in response to cosyntropin during adrenal vein sampling","volume":"104","author":"Wannachalee","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"issue":"9","key":"2021110612085587700_CIT0035","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1210\/jc.2018-00738","article-title":"Aldosterone suppression by dexamethasone in patients with KCNJ5-mutated aldosterone-producing adenoma","volume":"103","author":"Inoue","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"key":"2021110612085587700_CIT0036","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.mce.2015.04.022","article-title":"Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas","volume":"411","author":"Monticone","year":"2015","journal-title":"Mol Cell Endocrinol."},{"issue":"5","key":"2021110612085587700_CIT0037","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1210\/jc.2014-3551","article-title":"Diagnostic value of ACTH stimulation test in determining the subtypes of primary aldosteronism","volume":"100","author":"Jiang","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2021110612085587700_CIT0038","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1210\/jc.2015-3915","article-title":"Basal and post-ACTH aldosterone and its ratios are useful during adrenal vein sampling in primary aldosteronism","volume":"101","author":"El Ghorayeb","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"issue":"10","key":"2021110612085587700_CIT0039","doi-asserted-by":"crossref","first-page":"e3628","DOI":"10.1210\/clinem\/dgaa482","article-title":"The concordance between imaging and adrenal vein sampling varies with aldosterone-driver somatic mutation","volume":"105","author":"Wannachalee","year":"2020","journal-title":"J Clin Endocrinol Metab."},{"key":"2021110612085587700_CIT0040","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jsbmb.2019.01.008","article-title":"Classification of microadenomas in patients with primary aldosteronism by steroid profiling","volume":"189","author":"Yang","year":"2019","journal-title":"J Steroid Biochem Mol Biol."},{"issue":"4","key":"2021110612085587700_CIT0041","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1161\/HYPERTENSIONAHA.118.12070","article-title":"Genetic characteristics of aldosterone-producing adenomas in blacks","volume":"73","author":"Nanba","year":"2019","journal-title":"Hypertension."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgab420\/38873007\/dgab420.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/106\/10\/e3969\/41098081\/dgab420.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/106\/10\/e3969\/41098081\/dgab420.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T22:41:07Z","timestamp":1672440067000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/106\/10\/e3969\/6297181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,12]]},"references-count":41,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,6,12]]},"published-print":{"date-parts":[[2021,9,27]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgab420","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,10,1]]},"published":{"date-parts":[[2021,6,12]]}}}